AC
VYGR icon

Amia Capital’s Voyager Therapeutics VYGR Stock Holding History

Amia Capital’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,632
Closed -$156K – 28
2020
Q3 		$156K Sell
14,632
-438
-3% -$5.14K 0.18% 32
2020
Q2 		$190K Sell
15,070
-8,290
-35% -$96.4K 0.16% 34
2020
Q1 		$214K Buy
23,360
+3,677
+19% +$42.2K 0.19% 36
2019
Q4 		$275K Buy
+19,683
New +$286K 0.08% 40

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Amia Capital's VYGR Position: Q4 2020 in Review

Amia Capital sold out of Voyager Therapeutics (VYGR) in Q4 2020, closing a stake of 14,632 shares — an estimated $156K sold.

Amia Capital first reported a position in VYGR in Q4 2019 and held it in 4 quarters. The position peaked at $275K in Q4 2019. 101 funds tracked by Wall St. Rank hold VYGR as of Q4 2020.

  • Amia Capital reported no remaining Voyager Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 14,632 Voyager Therapeutics shares in Q4 2020, an estimated $156K.
  • Amia Capital first reported a position in Voyager Therapeutics in Q4 2019 and held it in 4 quarters.
  • Amia Capital's Voyager Therapeutics position peaked at $275K in Q4 2019.
  • 101 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.